Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines

Vaccine

Volumn 22, Issue 29-30, 2004, Pages 4101-4109

  Daly, Janet M ^a   Yates, Philip J ^a   Newton, J Richard ^a   Park, Andrew ^a,b   Henley, William ^a   Wood, James L N ^a   Davis Poynter, Nick ^a   Mumford, Jennifer A ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Equine; Influenza; Vaccine

Indexed keywords

ANTIBODY; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; BREEDING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EUROPE; HEMOLYSIS; HORSE DISEASE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROVOCATION TEST; REGRESSION ANALYSIS; VACCINATION; VIRUS STRAIN; WESTERN HEMISPHERE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; HEMAGGLUTININS, VIRAL; HORSE DISEASES; HORSES; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID; VACCINATION;

EID: 3242885091     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.048     Document Type: Article

References (34)

1. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem. 56:1987;365-394
2. Daniels R.S., Skehel J.J., Wiley D.C. Amino acid sequences of haemagglutinins of influenza viruses of the H3 subtype isolated from horses. J. Gen. Virol. 66:1985;457-464
3. Hannant D., Mumford J.A., Jessett D.M. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 122:1988;125-128
4. Wood J.M., Mumford J., Folkers C., Scott A.M., Schild G.C. Studies with inactivated equine influenza vaccine: I. Serological responses of ponies to graded doses of vaccine. J. Hyg. Camb. 90:1983;371-382
5. Mumford J. Progress in the control of equine influenza. In: Plowright W, Rossdale PD, Wade JF, editors. Equine infectious diseases VI. Cambridge: R & W Publications (Newmarket) Limited; 1992. p. 207-18.
6. Wood JLN. MSc., University of London, London, 1991.
7. Binns M.M., Daly J.M., Chirnside E.D., Mumford J.A., Wood J.M., Richards C.M., et al. Genetic and antigenic analysis of an equine influenza H3 isolate from the 1989 epidemic. Arch Virol. 130:1993;33-43
8. Daly J.M., Yates P.J., Browse G., Swann Z., Newton J.R., Jessett D., et al. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross-protection afforded by equine influenza vaccines. Equine Vet J. 35:2003;458-462
9. Daly J.M., Lai A.C.K., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A. Antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 77:1996;661-671
10. WHO. Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Centers for Disease Control; 1982.
11. Archetti I., Horsfall F.L. Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 92:1950;441-462
12. Macken C, Lu H, Goodman J, Boykin L. The value of a database in surveillance and vaccine selection. In: Cox N, Hampson AW, editors. Options for control of influenza IV, Osterhaus ADME, Elsevier Science; 2001. p. 103-6.
13. Felsenstein J. Phylogeny Inference Package (PHYLIP). version 3.6 edn. Distributed by the author, Department of Genetics, University of Washington, Seattle; 1993.
14. Wood JM, Mumford JA, Dunleavy U, Seagrott V, Newman RW, Thornton D, et al. Single radial immunodiffusion potency tests for inactivated equine influenza vaccines. In: Powell DG, editor. 5th International Conference of Equine Infectious Diseases, The University Press of Kentucky, Lexingon; 1987. p. 74-9.
15. Mumford J.A., Hannant D., Jessett D.M. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet. J. 22:1990;93-98
16. Mumford J., Wood J.M., Scott A.M., Folkers C., Schild G.C. Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J. Hyg. Camb. 90:1983;385-395
17. Petrie A, Watson P. Statistics for veterinary and animal science. Oxford: Blackwell Science; 1999.
18. Newton J.R., Townsend H.G.G., Wood J.L.N., Sinclair R., Hannant D., Mumford J.A. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equin-2 viruses (H3N8). Equine Vet. J. 32:2000;65-74
19. Newton J.R., Verheyen K., Wood J.L.N., Yates P.J., Mumford J.A. Equine influenza in the United Kingdom in 1998. Vet. Rec. 145:1999;449-452
20. Cook R.F., Sinclair R., Mumford J.A. Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. J. Virol. Meth. 20:1988;1-12
21. Livesay G.J., O'Neill T., Hannant D., Yadav M.P., Mumford J.A. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet. Rec. 133:1993;515-519
22. OIE. Conclusions and recommendations from the consultation meeting of OIE and WHO experts on equine influenza, Newmarket, United Kingdom, September 18-19. Office International des Epizooties Bulletin 1996;108:482-4.
23. Yates P., Mumford J.A. Equine influenza vaccine efficacy: the significance of antigenic variation. Vet. Microbiol. 74:2000;173-177
24. Burrows R., Denyer M., Goodridge D., Hamilton F. Field and laboratory studies of equine influenza viruses isolated in. Vet. Rec. 109:1981;353-356
25. Burrows R., Denyer M. Antigenic properties of some equine influenza viruses. Arch. Virol. 73:1982;15-24
26. Gelder C.M., Lambkin R., Hart K.W., Fleming D., Williams O.M., Bunce M., et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J. Infect. Dis. 185:2002;114-117
27. Poland G.A., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., et al. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine. 20:2002;430-438
28. Binns M, Hannant D, Wood J, Mumford J. Genetic influence on immune responses to equine vaccines. in Eighth International Conferenceon Equine Infectious Diseases R & W Publications (Newmarket) Ltd., Dubai, 1998. 477-8.
29. Park A.W., Wood J.L.N., Newton J.R., Daly J., Mumford J.A., Grenfell B.T. Optimising vaccination strategies in equine influenza. Vaccine. 21:2003;2862-2870
30. Park AW, Wood JLN, Daly JM, Newton JR, Glass K, Henley W, et al. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Proc Nat Acad Sci B, 2004; in press.
31. Haaheim L.R., Schild G.C. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses 2. Antiviral activities of the antibodies in biological systems. Acta. Path. Microbiol. Scand B. 88:1980;335-340
32. Heldens J.G.M., Wouw J.C.A.V.D., Loon A.A.W.M. An updated equine influenza vaccine and an equine influenza-herpesvirus combination vaccine containing an Immunostim adjuvant provoke equal antibody lelves in young foals throughout the primary vaccination course. Vet. J. 164:2002;288-291
33. Heldens J.G.M., Pouwels H.G.W., van Loon A.A.W.M. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet. J. 167:2004;150-157
34. Crouch CF, Daly J, Hannant D, Wilkins J, Francis MJ. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an American lineage H3N8 virus. Vaccine, in press.